Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Great Tree Pharmacy Co (ROCO:6469) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Great Tree Pharmacy Co Forward PE Ratio Related Terms
Great Tree Pharmacy Co Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Great Tree Pharmacy Co's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Great Tree Pharmacy Co Forward PE Ratio Chart
Great Tree Pharmacy Co Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
23.42
17.43
Great Tree Pharmacy Co Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
23.42
27.76
25.62
22.21
17.43
17.40
Great Tree Pharmacy Co Forward PE Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Great Tree Pharmacy Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Great Tree Pharmacy Co Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Great Tree Pharmacy Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Great Tree Pharmacy Co's Forward PE Ratio falls into.
Great Tree Pharmacy Co Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Great Tree Pharmacy Co (ROCO:6469) has a Forward PE Ratio of 16.57 as of Aug. 15, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Great Tree Pharmacy Co and its competitors. According to the industry distribution chart, Great Tree Pharmacy Co ranks #134 out of 315 companies in the Healthcare Providers & Services industry, placing it in the top 42.5%.
Is Great Tree Pharmacy Co's Forward PE Ratio too high?
Great Tree Pharmacy Co's current Forward PE Ratio is 16.57. The Healthcare Providers & Services industry median Forward PE Ratio is 19.02. Great Tree Pharmacy Co's value of 16.57 is 12.9% below this industry median. Based on the distribution chart, Great Tree Pharmacy Co ranks #134 out of 315 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Great Tree Pharmacy Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Great Tree Pharmacy Co's Forward PE Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Great Tree Pharmacy Co ranks #134 out of 315 companies for Forward PE Ratio. This puts Great Tree Pharmacy Co in the upper half of its industry. The industry median Forward PE Ratio is 19.02. Great Tree Pharmacy Co's value of 16.57 is 12.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 19.02, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Great Tree Pharmacy Co's current Forward PE Ratio of 16.57 is 12.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Great Tree Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 19.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Great Tree Pharmacy Co's current Forward PE Ratio is 16.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Great Tree Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Great Tree Pharmacy Co (ROCO:6469) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$168.74, compared to a current price of NT$69.80 — trading 58.6% below its estimated fair value. The current Forward PE Ratio is 16.57 and 12.9% below the Healthcare Providers & Services industry median of 19.02. Great Tree Pharmacy Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Great Tree Pharmacy Co (ROCO:6469), the current Forward PE Ratio is 16.57 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Great Tree Pharmacy Co (ROCO:6469) Overvalued in 2026?
Based on GuruFocus' analysis, Great Tree Pharmacy Co stock appears to be undervalued.
The current stock price of NT$69.80 is trading 58.6% below its estimated GF Value™ of NT$168.74.
GuruFocus considers Great Tree Pharmacy Co to be Significantly Undervalued.
Key valuation signals for ROCO:6469:
Forward PE Ratio: 16.57
GF Value™: NT$168.74 vs. price of NT$69.80 (58.6% below fair value)
Industry Position: 12.9% below the Healthcare Providers & Services median (#134 of 315)
No single metric tells the full story. See the ROCO:6469 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Great Tree Pharmacy Co Ltd engages in management and trading of various drugs, health supplements, maternity and infant products, and cosmetics products. It also provides coordinated medicine procurement services to various clinics, outpatient centers, and medical communities. Besides, it is also an agency for domestic and foreign health care products sold in clinics, outpatient centers, and medical communities. Its products include infant formula, baby diapers, Maternal and Infant Related, Adult drinks, Nutrition and health care, Body care, Daily Necessities, medical equipment, and Pet products.
69GF Score
Get the complete analysis for ROCO:6469
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6469 has been successfully added to your 
